Skip to content
Search

Latest Stories

UK scientists develop gadget that sniffs out Covid-19

Electronic devices may soon be used to identify the presence of infection in a crowded space using body odour profiles after scientists in the UK have tested a so-called 'Covid alarm'.

Early studies by scientists at the London School of Hygiene and Tropical Medicine (LSHTM) and Durham University show that Covid-19 infection has a distinct smell, resulting from changes in the volatile organic compounds (VOC) which make up the body odour – generating an odour “fingerprint” that the sensors can detect.


Led by researchers from the LSHTM and biotech company RoboScientific Ltd with Durham University, the study tested devices with organic semi-conducting (OSC) sensors, which could potentially be used as a Covid-19 screening tool.

“These results are really promising and demonstrate the potential for using this technology as a rapid, non-invasive test with incredible accuracy. However, further testing is required to confirm if these results can be replicated in real-world settings,” said Professor James Logan, Head of the Department of Disease Control at LSHTM, who led the study.

“If these devices are successfully developed for use in public places, they could be affordably and easily scaled up. They also could protect people against future disease outbreaks, with capability to develop sensor arrays to detect other diseases within a number of weeks,” he said.

The pre-print study, which is not yet peer-reviewed, used body odour samples from socks worn and donated to the team by 54 individuals – 27 Covid-19 positive individuals who were asymptomatic or had mild symptoms, and 27 uninfected individuals.

These samples were analysed by RoboScientific’s Model 307B VOC analyser fitted with an array of 12 OSC sensors. The samples were collected as part of a wider study led by LSHTM, in collaboration with Medical Detection Dogs and Durham University.

The OSC sensors captured the odour profile of the samples, having been tuned to be sensitive to the VOCs associated with Covid-19 infection, primarily ketone and aldehyde compounds.

“Many diseases have a distinct smell associated with them. We started our research with a blank sheet of paper and asked the question: Does Covid-19 have a distinct smell,” explained Professor Steve Lindsay, from the Department of Biosciences at Durham University.

“We ended the research showing a clear separation between the odours of people infected with the virus and those uninfected. Covid most definitely has a very distinct smell. This is real discovery science and very exciting for the development of screening methods for the disease,” he said.

Over two days of testing the samples, the researchers found the sensors were able to distinguish between infected and uninfected samples, demonstrating that SARS-CoV-2 (Covid-19) infection has a distinct odour.

On the first day of testing they achieved an average of 98 per cent specificity (meaning a low risk of false positive results) and an average of 99 per cent sensitivity (meaning a low risk of false negative results).

On the second day of testing the sensors achieved 100 per cent sensitivity and specificity, suggesting they can detect the presence of Covid-19 infection more accurately than any other diagnostic test available.

The Cambridgeshire-based start-up, RoboScientific, is exploring the potential of two types of device underpinned by these findings to enable fully-automated Covid-19 screening – a portable handheld device and a room-based device.

The device, developed from RoboScientific’s existing technology for early disease detection, could detect if a person is Covid-19 positive from their body odour. If deployed in public spaces, these devices could be used in place of PCR and LFT testing as a faster, less invasive diagnostic to inform an individual whether they are infected and required to self-isolate. They can be used with a separate air sampler or individual breath or mask samples.

Stan Curtis, CEO of RoboScientific, said: “Our experience in consumer electronics, coupled with five years developing our unique sensors for agricultural applications, has enabled us to create a new way of sensing VOCs.

“Our disease detection platform can provide fast accurate screening for diseases so that we will be ready if/when the next pandemic arrives.”

The device could screen areas such as classrooms or aircraft cabins to detect if an infected individual is in the room, with air analysis results within an estimated 30 minutes.

If Covid-19 positive odour is detected, all those in the room would need to be individually tested to determine who was infected as the device would only detect the presence of infection, not who is infected.

It would therefore not be designed to replace PCR [Polymerase chain reaction] or LFT [Lateral Flow Test] testing, but rather for use alongside these strategies to allow more targeted testing, saving money and time, and reducing onward transmission.

These devices were developed by adapting technology previously used in chicken houses to detect disease in flocks of up to 50,000 chickens, using well proven sampling methods and analysis.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less